Sp1135

SURGICAL MANAGEMENT OF BILIARY AND INTESTINAL OBSTRUCTION BECAUSE OF PANCREATIC HEAD DISEASE

Date
May 21, 2024

Speaker

Speaker Image for Jin He
Johns Hopkins University

Tracks

Related Products

Thumbnail for SURVODUTIDE REDUCES LIVER FAT CONTENT, TRANSAMINASES, AND FIBROSIS MARKERS WITH GOOD SAFETY PROFILE IN PEOPLE WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): AN INTERIM ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL
SURVODUTIDE REDUCES LIVER FAT CONTENT, TRANSAMINASES, AND FIBROSIS MARKERS WITH GOOD SAFETY PROFILE IN PEOPLE WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): AN INTERIM ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL
BACKGROUND: Survodutide is a novel glucagon receptor/glucagon-like peptide-1 receptor dual agonist under investigation for treatment in advanced liver disease associated with metabolic dysfunction-associated steatohepatitis (MASH), the most severe form of metabolic dysfunction-associated steatotic…
Thumbnail for A COMPARATIVE EVALUATION OF FIBROSIS AMONG PATIENTS WITH RECURRENT ACUTE AND CHRONIC PANCREATITIS UNDERGOING TOTAL PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION (TPIAT)
A COMPARATIVE EVALUATION OF FIBROSIS AMONG PATIENTS WITH RECURRENT ACUTE AND CHRONIC PANCREATITIS UNDERGOING TOTAL PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION (TPIAT)
Fibrosis is commonly used as the criterion standard for diagnosing chronic pancreatitis (CP). However, there has never been a study comparing fibrosis among patients with recurrent acute pancreatitis (RAP) and CP…